Menu

Upcoming Events

Submit your Events
Back to Search

The Ugly Truth about AI in Healthcare

Thursday, June 20, 2024 (1:00 PM - 2:00 PM) (EDT)

Description

The ugly truth about AI in healthcare is that it is an extremely arduous and challenging technology to tame. ChatGPT and similar large language models (LLMs) have captured the attention and imagination of the world. The potential for healthcare is real and worthy of significant excitement and hope. The reality is that it is a very different AI tool that produces the precise and accurate outputs that are required in most medical use cases than generative AI which covers a staggeringly broad range of topics with only pretty good accuracy. Healthcare will demand very focused and specific AI tools that require a structured and rigorous training process in order to be fit for purpose.

In this webinar, our panel of experts will go beyond LLMs to discuss AI’s role in the medical world and the challenges involved. It is easy to get lost in the seemingly endless possibility that AI introduces to the MedTech industry, but it is even easier to get off course in the planning and development of an AI algorithm.

Attendees will walk away with an understanding of:

  • Key elements of structuring an AI development effort that results in a tool that is fit for a specific purpose
  • Important early considerations, get a sense of the order of operations for AI development
  • Some unique considerations and trade-offs of developing these tools in the regulated environment


Register Now


SPEAKERS


Matt Eisendrath
President and Chief Commercial Officer
Full Spectrum

Matt is an innovative leader within the Life Sciences and Medical Device industry, joining Full Spectrum after leading Medical Device and Life Sciences in the Americas for Capgemini. A proven strategic thinker and leader with over 20 years in the healthcare industry, Matt has experience leading and growing businesses and divisions that maintain high and differentiated value in the market. An entrepreneur at heart, Matt understands the interplay and impact of technology, industry challenges/opportunities, and regulatory evolution and has worked throughout the industry forging the creative teaming relationships required to develop market changing products.


Rose Higgins 

CEO
Dr. Evidence


Rose Higgins is CEO of Dr.Evidence, the evidence-based insights platform for life sciences. A career healthcare innovator, Higgins was most recently CEO of HealthMyne, a pioneering radiomics company whose IP and technology assets were acquired by Genentech (a Roche company) in 2022. She began her career in nursing at the University of Pittsburgh Medical Center, followed by advancing roles in clinical and care management. Transitioning to leadership in healthcare IT organizations, Higgins took on executive roles with increasing responsibility in organizations including McKesson Corporation and SCIO Health Analytics (acquired by EXL Service Holdings) over a successful 20-year period. Higgins is known for her results-oriented approach, deep domain knowledge, and client satisfaction.


Rose received her Bachelor of Science in Nursing from Duquesne University, and her Master of Public Management from Carnegie Mellon University.



Raid Afana
Senior Director / Program Leader
Roche

Raid Afana is an accomplished healthcare executive with over 20 years of experience in the medical device and software industries. Currently a Senior Director/Program Leader at Roche, Patients Insights Lifecycle Team, delivering innovative Software as a Medical Device (SaMD) products and managing a diverse product portfolio. Afana has a proven track record in launching digital health solutions and diagnostic imaging devices, notably spearheading the launch of the Floodlight MS SaMD. Previously, he played a pivotal role in establishing the Digital Health Solutions business at Roche, managing multiple market releases and leading the MDR certification program. At Varian Medical Systems, Afana was instrumental in transforming the Particle Therapy Business into a market leader and achieving rapid FDA clearance for proton treatment devices. His tenure at Philips Healthcare saw him leading R&D for healthcare informatics solutions, driving agile release cycles, and optimizing engineering processes. His strategic vision and expertise continue to drive innovation and excellence in the healthcare industry.
Thursday, June 20, 2024 (1:00 PM - 2:00 PM) (EDT)
Powered By GrowthZone